Sorafenib in Combination with Oxaliplatin, Leucovorin, and Fluorouracil (Modified FOLFOX6) as First-line Treatment of Metastatic Colorectal Cancer: The RESPECT Trial (Q58614513)
Jump to navigation
Jump to search
scientific article published on 26 March 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sorafenib in Combination with Oxaliplatin, Leucovorin, and Fluorouracil (Modified FOLFOX6) as First-line Treatment of Metastatic Colorectal Cancer: The RESPECT Trial |
scientific article published on 26 March 2013 |
Statements
Sorafenib in combination with oxaliplatin, leucovorin, and fluorouracil (modified FOLFOX6) as first-line treatment of metastatic colorectal cancer: the RESPECT trial (English)
James Cassidy
Alberto Sobrero
Eric Van Cutsem
Claus-Henning Köhne
Sabine Tejpar
Oleg Gladkov
Irina Davidenko
Ramon Salazar
Liubov Vladimirova
Sergey Cheporov
Olga Burdaeva
Fernando Rivera
Irina Bulavina
Vanessa Potter
Yu-Lin Chang
Nathalie A Lokker
Peter J O'Dwyer